Objectives-The exact regulation ofthe synthesis of cartilage specific molecules, such as collagen type II and aggrecan, by articular chondrocytes is unknown, but growth factors and hormones probably play an important part. The effects of glucocorticosteroids (prednisolone and triamcinolone), in combination with insulin-like growth factor I (IGF-I), on the synthesis and hydrodynamic volume of proteoglycans from murine patellar cartilage were investigated. Methods 
important part. The effects of glucocorticosteroids (prednisolone and triamcinolone), in combination with insulin-like growth factor I (IGF-I), on the synthesis and hydrodynamic volume of proteoglycans from murine patellar cartilage were investigated. Methods-The in vitro effect of IGF-I and steroids on proteoglycan synthesis in murine patellar cartilage was evaluated by
[35S]sulphate incorporation in combination with dissociative gel chromatography using a Sephacryl S-1000 column. The impact ofin vivo prednisolone (0-5 mg/kg) on proteoglycan synthesis in murine pateliar cartilage was analysed by [35S] sulphate incorporation immediately after dissection from the knee joint. Results-Prednisolone stimulated proteoglycan synthesis in murine pateliar cartilage from normal knees and in cartilage from knees injected with papain in vitro in the absence and presence of IGF-I. Moreover, oral administration of prednisolone for seven days to C57B110 mice resulted in enhanced proteoglycan synthesis in patellar cartilage. The incubation of patellar cartilage for 48 hours without serum or growth factors led to the synthesis of proteoglycans with a smaller hydrodynamic volume than those synthesised immediately after dissection of the patellae. This could either be circumvented by the addition of IGF-I or by the addition of glucocorticosteroids (prednisolone or triamcinolone) to the culture medium. Conclusions-These results show that in a dose range of 00003-03 mmol/l, glucocorticosteroids, like IGF-I, stimulate proteoglycan synthesis and maintain the synthesis of hydrodynamically large proteoglycans by chondrocytes from murine articular cartilage. This indicates that glucocorticosteroids might play a part in the preservation of matrix integrity in articular cartilage.
(Ann Rheum Dis 1993; 52: 734-741) Articular cartilage consists of chondrocytes embedded in an extracellular matrix rich in collagen type II and the hyaluronic acid binding, cartilage specific proteoglycan aggrecan. Aggrecan gives articular cartilage its unique ability to resist compression and to undergo reversible deformation, whereas collagen provides tensile strength. Control of chondrocyte biosynthetic function is essential in the maintenance and integrity of this tissue. Disturbances in the metabolism of the articular chondrocytes, as in osteoarthritis and arthritis, will lead to the deterioration of articular cartilage and eventually to joint failure. Insulin-like growth factor I (IGF-I) is considered to be a cardinal factor in the maintenance of chondrocyte biosynthetic function. This factor appears to be as effective as serum in stimulating proteoglycan synthesis in bovine, human, and murine chondrocytes.`-Although it has been reported that IGF-I has no effect on proteoglycan degradation in bovine explants, other workers have observed considerable inhibition of proteoglycan breakdown by IGF-I in bovine and murine cartilages.' [5] [6] [7] Glucocorticosteroid receptors have been shown to be present on articular cartilage chondrocytes, indicating that chondrocyte metabolism can be influenced directly by physiological and therapeutic glucocorticoids.8 ' The specific effects of glucocorticosteroids on chondrocyte proteoglycan synthesis are conflicting, however, and remain controversial. An inhibitory effect of glucocorticosteroids on proteoglycan synthesis has been reported for normal rat, bovine, and porcine chondrocytes'S'2 and human osteoarthritic cartilage.'3 In contrast, the maintenance of differentiated chondrocyte phenotype and proteoglycan synthesis are stimulated in rabbit chondrocytes by glucocorticosteroids. [14] [15] [16] Moreover, there appears to be a synergistic action of glucocorticosteroids and IGF-I on proteoglycan synthesis in rabbit chondrocytes. 17 In this study we After incubation the patellae were washed three times with physiological saline to remove non-incorporated radiolabel and were subsequently fixed in 96% ethanol. Decalcification of the patellae with 5% formic acid was followed by stripping of the articular cartilage layer from the remainder of the patella. Murine patellae were dissected from normal knee joints and knee joints injected with papain. The patellae were incubated for 48 hours in the presence and absence of IGF-I (0-25 ,ug/ml) and various concentrations of prednisolone or triamcinolone acetonide (Sigma; 0, 0 03, and 0 3 mmolI1). After incubation the patellae were cultured for four hours in RPMI 1640 DM medium containing 6 MBq [35S]sulphate followed by a thorough rinsing in physiological saline. In additional experiments the labelling interval was followed by a 24 hour chase period in medium containing similar supplements to the original incubation medium.
Subsequently, the patellae were decalcified in 3.5% Na2-EDTA (Merck, Darmstadt, Germany),for four hours and thereafter the cartilage layer was stripped from the bone. The stripped cartilage was ground with a glass mortar and pestle followed by proteoglycan extraction at 4°C for 24 hours with 4 M guanidinium hydrochloride (Merck) in the presence of protease inhibitors (0-01 M EDTA, 0-1 M 6-aminocaproic acid (Sigma), 0 005 M benzamidine hydrochloride (Sigma), 5 mg/ml trypsin inhibitor (Sigma), 0 005 M iodoacetate (Sigma)). This extraction procedure resulted in the extraction of over 90% of the incorporated radiolabel. Extracted proteoglycans were supplemented with 1 mg of an unlabelled bovine proteoglycan mixture as a carrier and applied to a Sephacryl S-1000 column (1 6 X 100 cm, Pharmacia, Uppsala, Sweden). The column was equilibrated and eluted with 4 M guanidinium chloride (dissociative). The flow rate was 6 ml/h and fractions of 3 ml were collected. The fractions were assayed for radioactively labelled proteoglycans using a liquid scintillation counter. All runs were checked for reproducibility by comparison of the elution pattern of the unlabelled bovine carrier proteoglycans of different runs. All runs of one particular experiment were performed on the same column. EFFECT Statistical significance was analysed with respect to the control group after one way analysis of variance.
proteoglycans with a hydrodynamic volume comparable with those synthesised ex vivo. In the presence of 0 03 mmol/l, however, some of the synthesised proteoglycans were still smaller than the proteoglycans produced normally. Prednisolone had no effect on the hydrodynamic volume of the proteoglycans in the presence of IGF-I ( fig 4) . As expected, the effect of prednisolone on the dimension of newly synthesised proteoglycans did not appear to be specific to prednisolone. Triamcinolone acetonide had effects analogous to prednisolone on the hydrodynamic volume of newly synthesised proteoglycans ( fig 5) . Concentrations of 0-03 and 0 3 mM triamcinolone enhanced the synthesis of hydrodynamically large proteoglycans by patellar cartilage cultured in the absence of IGF-I ( fig 5A) . In the presence of IGF-I, no effects of triamcinolone were detectable on the proteoglycan hydrodynamic volume ( fig 5C) .
During a 24 hour chase period approximately 50% of the proteoglycans was lost in the absence of IGF-I, whereas this was only 20% in the presence of IGF-I. Triamcinolone had no effect on proteoglycan loss during the 24 hour chase period. The Fraction Figure 4 Effect ofprednisolone on hydrodynamic volume of newly synthesiscd proteoglycans of normal patellar cartilage, in the presence and absence of insulin-like growth factor I (IGF-I). Proteoglycans were radiolabelled with /'5S]sulphateforfour hours after 48 hours of incubation with prednisolone. Proteoglycans were applied to a Sephacryl S-1 000 column and eluted under dissociative conditions. * = 0 molIl; + = 0-03 mmol/l; and * = 0 3 mmolJI prednisolone. One representative experiment offour is shown.
chromatographic profiles obtained immediately after labelling and after a 24 hour chase period were essentially similar (fig 5B and D) . Only a slight shift to a larger hydrodynamic volume of the proteoglycans was observed. concentration and an enhanced proteoglycan synthesis rate was as responsive to IGF-I as normal cartilage. The hydrodynamic volume of the subpopulation of large proteoglycans of murine patellar cartilage appeared to be smaller than that of proteoglycans from bovine articular cartilage (our results, data not shown). This appears to be a general phenomenon. A smaller size of murine monomers compared with monomers from comparable tissues of larger species has been reported for proteoglycans from murine articular cartilage and from murine intervertebral disc.20 21 The exact nature of the small molecular weight proteoglycans synthesised by patellar cartilage cultured without IFG-I, probably biglycan or decorin, is under study.
Other workers have reported that IGF-I preferentially stimulates the synthesis of large proteoglycans by chondrocytes. In experiments with rat rib growth plate chondrocytes, incubation with IGF-I resulted in an increased size of the newly synthesised proteoglycan monomers. 22 In contrast, other growth factors such as epidermal growth factor and fibroblast growth factor favoured the synthesis of small proteoglycans. 22 In bovine articular cartilage explants, IGF-I only stimulated the synthesis of the large proteoglycan subpopulation, but had no effect on the synthesis of small proteoglycans. 23 These observations suggest that IGF-I is able to prevent the dedifferentiating effect of prolonged in vitro incubation when judged by the synthesis of proteoglycans.
Incubation of patellar cartilage for 24 hours with rather high concentrations of prednisolone (00003-03 mmolIl) resulted in a stimulation of [35S] sulphate incorporation and only at a concentration of 3 mmolAl was no stimulation or only a slight, insignificant inhibition seen. With respect to the rate of proteoglycan synthesis, no significant difference in prednisolone effects was observed between cultures with or without IGF-I, neither with normal cartilage nor with cartilage from knees injected with papain. Moreover, in vivo administration of prednisolone up to the highest dose tested (5 mg/kg) led to a significant stimulation of ex vivo proteoglycan synthesis in cartilage from normal knees and knees injected with papain. This is in agreement with the observation that proteoglycan synthesis in isolated rabbit chondrocytes was stimulated by glucocorticosteroids.'F'6 In earlier studies with anatomically intact murine cartilage it was found that 03 mM prednisolone had no significant effect on proteoglycan synthesis in normal cartilage, but stimulated proteoglycan synthesis in trypsin depleted cartilage and in cartilage from knee joints injected with zymozan. 24 In contrast with these observations, an inhibiting effect of glucocorticosteroids on proteoglycan synthesis in articular cartilage has been shown by others. Dekel et al observed an inhibitory effect of hydrocortisone, at a concentration of 3 
